Natalia Anatolyevna Belykh
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Natalia Anatolyevna Belykh has a total of 182 co-authors. Here are the top co-authors by number of shared publications:
- Inna Vladimirovna Piznyur
Ryazan State Medical University
20 shared publications - Elena V. Stezhkina
Federal State Budgetary Educational Institution of Higher Education “Ryazan State Medical University named after Academician I. P. Pavlov” of the Ministry of Health of the Russian Federation
11 shared publications - Наталья Александровна Аникеева
Ryazan State Medical University
7 shared publications - Yu. V. Deeva
Ryazan State Medical University
6 shared publications - Polina Olegovna Kotova
Ryazan State Medical University
5 shared publications Ryazan State Medical University
5 shared publications
Latest Publications
- 16 November 2026
- Published by The National Academy of Pediatric Science and Innovation in Rossiyskiy Vestnik Perinatologii i Pediatrii (Russian Bulletin of Perinatology and Pediatrics)
- Vol. 71 (5)
МicroRNA as promising biomarkers of obesity comorbidities in childhood
The growing number of obese children creates the need to find modern indicators for the early detection of concomitant diseases. Candidates for the role of biomarkers may be microRNAs that naturally suppress gene expression. Objective. To present and summarize information about the features of microRNA expression in children with obesity and comorbid pathology. Materials and methods. The results of studies on the assessment of microRNA expression in childhood obesity complications were searched using Scopus, Web of Science, PubMed, Google Scholar, eLibrary, and Cyberleninka databases. Results. Studies on endothelial dysfunction in childhood obesity have identified microRNAs-320a and -630 as possible indicators of diagnosis and treatment. The search for alternative markers for the diagnosis of metabolic dysfunction-associated steatotic liver disease has revealed the value of several signaling molecules (microRNAs-199a-5p, -22, -122, -486, -146b and -15b), which can also be used to assess the risk of type 2 mellitus, metabolic syndrome and insulin resistance in children. No significant relationship has been established between the studied microRNAs and atherosclerosis. Conclusion. MicroRNAs are promising prognostic markers for the early detection of endothelial dysfunction, metabolic associated steatotic liver disease, type 2 diabetes, metabolic syndrome, and insulin resistance in obese children.
- 16 November 2026
- Published by The National Academy of Pediatric Science and Innovation in Rossiyskiy Vestnik Perinatologii i Pediatrii (Russian Bulletin of Perinatology and Pediatrics)
- Vol. 71 (5)
МicroRNA as promising biomarkers of obesity comorbidities in childhood
The growing number of obese children creates the need to find modern indicators for the early detection of concomitant diseases. Candidates for the role of biomarkers may be microRNAs that naturally suppress gene expression. Objective. To present and summarize information about the features of microRNA expression in children with obesity and comorbid pathology. Materials and methods. The results of studies on the assessment of microRNA expression in childhood obesity complications were searched using Scopus, Web of Science, PubMed, Google Scholar, eLibrary, and Cyberleninka databases. Results. Studies on endothelial dysfunction in childhood obesity have identified microRNAs-320a and -630 as possible indicators of diagnosis and treatment. The search for alternative markers for the diagnosis of metabolic dysfunction-associated steatotic liver disease has revealed the value of several signaling molecules (microRNAs-199a-5p, -22, -122, -486, -146b and -15b), which can also be used to assess the risk of type 2 mellitus, metabolic syndrome and insulin resistance in children. No significant relationship has been established between the studied microRNAs and atherosclerosis. Conclusion. MicroRNAs are promising prognostic markers for the early detection of endothelial dysfunction, metabolic associated steatotic liver disease, type 2 diabetes, metabolic syndrome, and insulin resistance in obese children.
- Open Access
- 30 September 2026
- Published by ECO-Vector LLC (Publications) in Annals of Clinical and Experimental Neurology
- Vol. 20 (3) , 80-85
Clinical case of Zhu–Tokita–Takenouchi–Kim syndrome
Zhu–Tokita–Takenouchi–Kim syndrome is an extremely rare hereditary disorder belonging to the group of nuclear speckleopathies with an autosomal dominant inheritance pattern. To date, only approximately 87 confirmed cases have been described in the global medical literature, underscoring the exceptional rarity of this condition. Its pathogenesis is driven by mutations in the SON gene, which plays a critical role in RNA splicing and the regulation of embryonic development. The clinical presentation of the syndrome is highly polymorphic and manifests from birth. Key features include significant motor and psychomotor and speech developmental delay, generalized muscle hypotonia, and intellectual disability of varying severity. Characteristic facial dysmorphism includes macrocephaly or dolichocephaly, hypertelorism, a broad nasal bridge, and a thin upper lip. Central nervous system abnormalities often include structural malformations such as hypoplasia of the corpus callosum and cortical dysplasia. In addition to neurological impairments, patients may present with musculoskeletal anomalies (scoliosis, pectus carinatum, joint contractures) and ocular disorders (optic atrophy, strabismus, microcornea). This article presents our own clinical observation of the disease in an 8-year-old child, contributing to the description of the natural history and long-term outcomes of the syndrome. Analysis of such cases is fundamental to better understanding the pathophysiology of the disease and developing palliative care strategies aimed at improving patients' quality of life.
- 30 September 2026
- Published by ECO-Vector LLC (Publications) in Annals of Clinical and Experimental Neurology
- Vol. 20 (3) , 80-85
Open AccessClinical case of Zhu–Tokita–Takenouchi–Kim syndrome
Zhu–Tokita–Takenouchi–Kim syndrome is an extremely rare hereditary disorder belonging to the group of nuclear speckleopathies with an autosomal dominant inheritance pattern. To date, only approximately 87 confirmed cases have been described in the global medical literature, underscoring the exceptional rarity of this condition. Its pathogenesis is driven by mutations in the SON gene, which plays a critical role in RNA splicing and the regulation of embryonic development. The clinical presentation of the syndrome is highly polymorphic and manifests from birth. Key features include significant motor and psychomotor and speech developmental delay, generalized muscle hypotonia, and intellectual disability of varying severity. Characteristic facial dysmorphism includes macrocephaly or dolichocephaly, hypertelorism, a broad nasal bridge, and a thin upper lip. Central nervous system abnormalities often include structural malformations such as hypoplasia of the corpus callosum and cortical dysplasia. In addition to neurological impairments, patients may present with musculoskeletal anomalies (scoliosis, pectus carinatum, joint contractures) and ocular disorders (optic atrophy, strabismus, microcornea). This article presents our own clinical observation of the disease in an 8-year-old child, contributing to the description of the natural history and long-term outcomes of the syndrome. Analysis of such cases is fundamental to better understanding the pathophysiology of the disease and developing palliative care strategies aimed at improving patients' quality of life.
- 5 August 2026
- Published by Media Sphere Publishing Group in Russian Journal of Preventive Medicine
- Vol. 29 (7) , 119-125
Trimethylamine-N-oxide as a marker of a human metabolism
Trimethylamine N-oxide (TMAO), an organic compound produced by gut microbiota from dietary precursors, has been considered in recent years as a biomarker of the body's metabolic state. Objective. To summarize and present current data on the biosynthesis of trimethylamine N-oxide, its physiological functions and pathological consequences of elevated serum concentrations of this metabolite, to substantiate the opportunities for improving the effectiveness of preventive measures. Materials and methods. A search for domestic and international literature on the physiological functions and consequences of elevated serum TMAO concentration, as well as potential interventions aimed at improvement of the effectiveness of cardiovascular pathology prevention, was carried out. The following databases were used for the search: Scopus, Web of Science, PubMed, Google Scholar, eLibrary, Cyberleninka. Results. We searched for full-text sources in Russian and English containing research findings on the relationship between elevated TMAO level and the development of cardiovascular pathology. In particular, TMAO-induced mechanisms include endothelial dysfunction, inflammation and impaired cholesterol metabolism, which together trigger atherosclerosis and cause its progression. Conclusion. Trimethylamine N-oxide plays a key role in the complex interaction between diet, gut microbiota and human health. Elevated level of trimethylamine N-oxide create conditions for the development of endothelial dysfunction, inflammation and atherosclerosis, which emphasizes the need to find effective strategies aimed at normalizing the level of this metabolite. The innovative potential of influencing trimethylamine N-oxide level through nutraceutical and microbiome modulating strategies offers a modern, personalized approach to the prevention of metabolic disorders.
- 5 August 2026
- Published by Media Sphere Publishing Group in Russian Journal of Preventive Medicine
- Vol. 29 (7) , 119-125
Trimethylamine-N-oxide as a marker of a human metabolism
Trimethylamine N-oxide (TMAO), an organic compound produced by gut microbiota from dietary precursors, has been considered in recent years as a biomarker of the body's metabolic state. Objective. To summarize and present current data on the biosynthesis of trimethylamine N-oxide, its physiological functions and pathological consequences of elevated serum concentrations of this metabolite, to substantiate the opportunities for improving the effectiveness of preventive measures. Materials and methods. A search for domestic and international literature on the physiological functions and consequences of elevated serum TMAO concentration, as well as potential interventions aimed at improvement of the effectiveness of cardiovascular pathology prevention, was carried out. The following databases were used for the search: Scopus, Web of Science, PubMed, Google Scholar, eLibrary, Cyberleninka. Results. We searched for full-text sources in Russian and English containing research findings on the relationship between elevated TMAO level and the development of cardiovascular pathology. In particular, TMAO-induced mechanisms include endothelial dysfunction, inflammation and impaired cholesterol metabolism, which together trigger atherosclerosis and cause its progression. Conclusion. Trimethylamine N-oxide plays a key role in the complex interaction between diet, gut microbiota and human health. Elevated level of trimethylamine N-oxide create conditions for the development of endothelial dysfunction, inflammation and atherosclerosis, which emphasizes the need to find effective strategies aimed at normalizing the level of this metabolite. The innovative potential of influencing trimethylamine N-oxide level through nutraceutical and microbiome modulating strategies offers a modern, personalized approach to the prevention of metabolic disorders.
- Open Access
- 30 July 2026
- Published by Association of Pediatric Allergologists and Immunologists of Russia in Allergology and Immunology in Paediatrics
- No. 1,p. 6-184
Allergic rhinitis in children — a consensus document of the Association of Pediatric Allergists and Immunologists of Russia
Background. Allergic rhinitis (AR) is the most prevalent allergic disease globally, particularly within the pediatric population. Its high prevalence and substantial impact on quality of life render it a pressing clinical concern. Notable challenges persist in early diagnosis, comprehension of pathogenetic mechanisms, and optimization of therapeutic strategies, especially in young children. Objective. To present a contemporary review and consensus recommendations from the Association of Pediatric Allergists and Immunologists of Russia (APAIR) on the management of pediatric AR, encompassing pathogenetic mechanisms, risk factors, clinical presentation, diagnostic approaches, and therapeutic modalities. Materials and Methods. This work synthesizes current national and international research, including data from meta-analyses and clinical guidelines, alongside original expert contributions from APAIR members. Results. Experts conceptualize AR as a mixed immune-inflammatory disorder involving the classical IgE-dependent pathway (Type I), cellular responses (Type IV), and epithelial dysfunction (Type V). The significance of risk factors, including genetics, microbiome composition, pollutant exposure, and allergen contact, is underscored. Data on the substantial prevalence of AR are presented, highlighting its underdiagnosis in young children and patients with comorbid conditions such as atopic dermatitis and food allergy. A refined, more clinically applicable definition of AR is proposed. Algorithms for stepwise pharmacotherapy are thoroughly detailed, including the evidence-based use of antihistamines as initial therapy for young children and patients with mild AR, intranasal corticosteroids as the cornerstone of treatment, and fixed intranasal combinations for both baseline and on-demand therapy. A personalized approach based on age (0–18 years) and clinical phenotype is emphasized. APAIR experts underscore the role of allergen-specific immunotherapy (AIT) as the only disease-modifying intervention, in contrast to pharmacotherapy, which primarily provides symptomatic control. Conclusion. Timely diagnosis and appropriate, stepwise therapy for AR in children facilitate symptom control and significantly improve patients’ quality of life. Furthermore, the incorporation of AIT can prevent disease progression, including the development of bronchial asthma. This consensus document aims to assist clinicians in making evidence-based clinical decisions.
- 30 July 2026
- Published by Association of Pediatric Allergologists and Immunologists of Russia in Allergology and Immunology in Paediatrics
- No. 1,p. 6-184
Open AccessAllergic rhinitis in children — a consensus document of the Association of Pediatric Allergists and Immunologists of Russia
Background. Allergic rhinitis (AR) is the most prevalent allergic disease globally, particularly within the pediatric population. Its high prevalence and substantial impact on quality of life render it a pressing clinical concern. Notable challenges persist in early diagnosis, comprehension of pathogenetic mechanisms, and optimization of therapeutic strategies, especially in young children. Objective. To present a contemporary review and consensus recommendations from the Association of Pediatric Allergists and Immunologists of Russia (APAIR) on the management of pediatric AR, encompassing pathogenetic mechanisms, risk factors, clinical presentation, diagnostic approaches, and therapeutic modalities. Materials and Methods. This work synthesizes current national and international research, including data from meta-analyses and clinical guidelines, alongside original expert contributions from APAIR members. Results. Experts conceptualize AR as a mixed immune-inflammatory disorder involving the classical IgE-dependent pathway (Type I), cellular responses (Type IV), and epithelial dysfunction (Type V). The significance of risk factors, including genetics, microbiome composition, pollutant exposure, and allergen contact, is underscored. Data on the substantial prevalence of AR are presented, highlighting its underdiagnosis in young children and patients with comorbid conditions such as atopic dermatitis and food allergy. A refined, more clinically applicable definition of AR is proposed. Algorithms for stepwise pharmacotherapy are thoroughly detailed, including the evidence-based use of antihistamines as initial therapy for young children and patients with mild AR, intranasal corticosteroids as the cornerstone of treatment, and fixed intranasal combinations for both baseline and on-demand therapy. A personalized approach based on age (0–18 years) and clinical phenotype is emphasized. APAIR experts underscore the role of allergen-specific immunotherapy (AIT) as the only disease-modifying intervention, in contrast to pharmacotherapy, which primarily provides symptomatic control. Conclusion. Timely diagnosis and appropriate, stepwise therapy for AR in children facilitate symptom control and significantly improve patients’ quality of life. Furthermore, the incorporation of AIT can prevent disease progression, including the development of bronchial asthma. This consensus document aims to assist clinicians in making evidence-based clinical decisions.
- 17 April 2026
- Published by Scientific and Practical Reviewed Journal Pulmonology in PULMONOLOGIYA
- Vol. 36 (2)
Clinical “masks” of congenital pathology of the bronchopulmonary system
Congenital disorders of bronchopulmonary system are a group of rare diseases characterized by alterations in the morphological structure of the lungs, bronchi, and pulmonary blood vessels with manifestation in childhood. Congenital bronchopulmonary disorders are the third most common type of chronic lung and pulmonary conditions in children. The increase in the number of registered cases is associated with the use of modern imaging techniques, particularly computed tomography (CT). An urgent challenge in modern respiratory medicine is the development of methods for early diagnosis of congenital bronchopulmonary disorders, based on the integration and assessment of the diagnostic significance of key anamnestic, clinical and, potentially, radiological markers. The aim was to present the most common congenital bronchopulmonary disorders using clinical cases of patients with primary ciliary dyskinesia and bilateral congenital lobar emphysema. Methods. A retrospective analysis of the primary medical records of patients A and B (outpatient consultation reports and hospital discharge summaries) was performed, including an evaluation of their medical history, clinical presentation and diagnostic findings. Long-term personal follow-up data were also considered. Conclusion. Raising awareness among primary care paediatricians about congenital bronchopulmonary disorders, including primary ciliary dyskinesia and congenital lobar emphysema, is essential for achieving early diagnosis.
- 17 April 2026
- Published by Scientific and Practical Reviewed Journal Pulmonology in PULMONOLOGIYA
- Vol. 36 (2)
Clinical “masks” of congenital pathology of the bronchopulmonary system
Congenital disorders of bronchopulmonary system are a group of rare diseases characterized by alterations in the morphological structure of the lungs, bronchi, and pulmonary blood vessels with manifestation in childhood. Congenital bronchopulmonary disorders are the third most common type of chronic lung and pulmonary conditions in children. The increase in the number of registered cases is associated with the use of modern imaging techniques, particularly computed tomography (CT). An urgent challenge in modern respiratory medicine is the development of methods for early diagnosis of congenital bronchopulmonary disorders, based on the integration and assessment of the diagnostic significance of key anamnestic, clinical and, potentially, radiological markers. The aim was to present the most common congenital bronchopulmonary disorders using clinical cases of patients with primary ciliary dyskinesia and bilateral congenital lobar emphysema. Methods. A retrospective analysis of the primary medical records of patients A and B (outpatient consultation reports and hospital discharge summaries) was performed, including an evaluation of their medical history, clinical presentation and diagnostic findings. Long-term personal follow-up data were also considered. Conclusion. Raising awareness among primary care paediatricians about congenital bronchopulmonary disorders, including primary ciliary dyskinesia and congenital lobar emphysema, is essential for achieving early diagnosis.
- 17 April 2026
- Published by Scientific and Practical Reviewed Journal Pulmonology in PULMONOLOGIYA
- Vol. 36 (2)
The experience of using triple targeted therapy (elexacaftor/ tezacaftor/ivacaftor) in a patient with cystic fibrosis complicated by cystic fibrosis-related diabetes
This article discusses the clinical experience of using triple targeted therapy (elexacaftor/tezacaftor/ivacaftor) in a patient with cystic fibrosis complicated by cystic fibrosis-related diabetes. The description includes details on the diagnostic process, the features of the disease course, and treatment approaches. In addition, the work pays special attention to the use of targeted drugs, as well as the need for an integrated approach to managing the condition of patients with combined disorders. To date, there has been insufficient research on the efficacy of the drug elexacaftor/ tezacaftor/ivacaftor and its effects on patients with comorbid conditions, particularly those suffering from cystic fibrosis-related diabetes. The aim was to highlight modern research on this topic and to assess the effect of triple targeted therapy on the clinical manifestations of the disease. Results. The patient showed significant improvement in the functional state of the lungs, control of blood glucose levels, and overall quality of life. Conclusion. The article summarizes the importance of an individualized approach to therapy that considers both genetic and metabolic aspects of the disease. The conclusion emphasizes the importance of early, timely initiation of treatment to achieve optimal results and improve the prognosis of long-term life in patients with cystic fibrosis and related complications.
- 17 April 2026
- Published by Scientific and Practical Reviewed Journal Pulmonology in PULMONOLOGIYA
- Vol. 36 (2)
The experience of using triple targeted therapy (elexacaftor/ tezacaftor/ivacaftor) in a patient with cystic fibrosis complicated by cystic fibrosis-related diabetes
This article discusses the clinical experience of using triple targeted therapy (elexacaftor/tezacaftor/ivacaftor) in a patient with cystic fibrosis complicated by cystic fibrosis-related diabetes. The description includes details on the diagnostic process, the features of the disease course, and treatment approaches. In addition, the work pays special attention to the use of targeted drugs, as well as the need for an integrated approach to managing the condition of patients with combined disorders. To date, there has been insufficient research on the efficacy of the drug elexacaftor/ tezacaftor/ivacaftor and its effects on patients with comorbid conditions, particularly those suffering from cystic fibrosis-related diabetes. The aim was to highlight modern research on this topic and to assess the effect of triple targeted therapy on the clinical manifestations of the disease. Results. The patient showed significant improvement in the functional state of the lungs, control of blood glucose levels, and overall quality of life. Conclusion. The article summarizes the importance of an individualized approach to therapy that considers both genetic and metabolic aspects of the disease. The conclusion emphasizes the importance of early, timely initiation of treatment to achieve optimal results and improve the prognosis of long-term life in patients with cystic fibrosis and related complications.
- Open Access
- 26 March 2026
- Published by Rostov State Medical University in Medical Herald of the South of Russia
- Vol. 17 (1) , 32-36
A clinical case of air tract malformation in a teenager
Congenital cystic adenomatoid malformation (CCAM) of the lung is a congenital disorder characterized by multiple cysts resulting from adenomatous hyperplasia of the bronchial epithelium. In many cases, respiratory distress develops in the neonatal period, and approximately 80–85% of patients with CCAM are diagnosed before the age of two years old. CCAM diagnosed in adolescence is extremely rare. In this paper, we describe a case of CCAM of the right lung in a 15-year-old girl, which was discovered incidentally during a routine examination. Patient underwent a right upper partial lobectomy; histopathological examination confirmed the diagnosis.
- 26 March 2026
- Published by Rostov State Medical University in Medical Herald of the South of Russia
- Vol. 17 (1) , 32-36
Open AccessA clinical case of air tract malformation in a teenager
Congenital cystic adenomatoid malformation (CCAM) of the lung is a congenital disorder characterized by multiple cysts resulting from adenomatous hyperplasia of the bronchial epithelium. In many cases, respiratory distress develops in the neonatal period, and approximately 80–85% of patients with CCAM are diagnosed before the age of two years old. CCAM diagnosed in adolescence is extremely rare. In this paper, we describe a case of CCAM of the right lung in a 15-year-old girl, which was discovered incidentally during a routine examination. Patient underwent a right upper partial lobectomy; histopathological examination confirmed the diagnosis.
- Open Access
- 28 January 2026
- Published by Association of Pediatric Allergologists and Immunologists of Russia in Allergology and Immunology in Paediatrics
- No. 4,p. 9-23
Influence of birch bark dusting intensity on the peculiarities of the course of pollinosis in children
Rationale: the problem of the growth of allergic diseases associated with plant pollination is urgent. At present, numerous works discuss the influence of global warming on the onset, intensity and duration of plant pollination. An increase in the total annual pollen concentration in the aeropalynological spectrum is noted. For the Central Federal District (CFD) of Russia, pollination of woody wind-pollinated plants, particularly birch, is of the greatest clinical significance. Objective: to study the clinical characteristics of birch pollinosis in children of the city of Ryazan and Ryazan region in the season of 2023 in conditions of intensive dusting of birch (Betula). Materials and methods. An open single-centre retrospective randomized uncontrolled cohort study was conducted. The study included 211 children who sought emergency medical care from 01.02.2023 to 30.06.2023 in hospital or polyclinic with symptoms of bronchial asthma, allergic rhinitis and atopic dermatitis. The time frame of the study was February to June 2023. In parallel, prospective aerobiological monitoring with the help of Lanzoni volumetric trap ‘VPPS 2000’ and analysis of search queries of residents of Ryazan and Ryazan region in the system ‘Yandex Wordstat’ were conducted. For statistical processing of the obtained results, Past 4.03 software and SPSS V24.0 package were used, including descriptive statistics. Results. According to the data of aerobiological studies in the season 2023 record high concentration of birch pollen for the last 9 years of observations. This resulted in a high incidence of emergency visits to health care facilities with symptoms of pollinosis. The main age group of children who applied was from 7 to 12 years old, but there were also cases of children under 3 years old, which indicates rejuvenation of the pollynosis debut. There was a dependence on sex, as the number of boys who applied was 2.5 times higher than the number of girls who applied. Bronchial asthma predominated in the structure of clinical phenotypes of children urgently hospitalised, and half of all asthma cases were its manifestation. A moderate positive association (r = 0.4; p = 0.002) between airborne pollen concentration and the number of children who sought care was found in hospitalised patients when aeropalynological monitoring and clinic data were compared. Conclusion. The peculiarity of the pollen season in 2023 in the Ryazan region (Central Federal District of the Russian Federation) is the record high concentration of birch pollen for the last 9 years of observations. This led to an increase in the number of children with emergency symptoms of respiratory and cutaneous pollinosis.
- 28 January 2026
- Published by Association of Pediatric Allergologists and Immunologists of Russia in Allergology and Immunology in Paediatrics
- No. 4,p. 9-23
Open AccessInfluence of birch bark dusting intensity on the peculiarities of the course of pollinosis in children
Rationale: the problem of the growth of allergic diseases associated with plant pollination is urgent. At present, numerous works discuss the influence of global warming on the onset, intensity and duration of plant pollination. An increase in the total annual pollen concentration in the aeropalynological spectrum is noted. For the Central Federal District (CFD) of Russia, pollination of woody wind-pollinated plants, particularly birch, is of the greatest clinical significance. Objective: to study the clinical characteristics of birch pollinosis in children of the city of Ryazan and Ryazan region in the season of 2023 in conditions of intensive dusting of birch (Betula). Materials and methods. An open single-centre retrospective randomized uncontrolled cohort study was conducted. The study included 211 children who sought emergency medical care from 01.02.2023 to 30.06.2023 in hospital or polyclinic with symptoms of bronchial asthma, allergic rhinitis and atopic dermatitis. The time frame of the study was February to June 2023. In parallel, prospective aerobiological monitoring with the help of Lanzoni volumetric trap ‘VPPS 2000’ and analysis of search queries of residents of Ryazan and Ryazan region in the system ‘Yandex Wordstat’ were conducted. For statistical processing of the obtained results, Past 4.03 software and SPSS V24.0 package were used, including descriptive statistics. Results. According to the data of aerobiological studies in the season 2023 record high concentration of birch pollen for the last 9 years of observations. This resulted in a high incidence of emergency visits to health care facilities with symptoms of pollinosis. The main age group of children who applied was from 7 to 12 years old, but there were also cases of children under 3 years old, which indicates rejuvenation of the pollynosis debut. There was a dependence on sex, as the number of boys who applied was 2.5 times higher than the number of girls who applied. Bronchial asthma predominated in the structure of clinical phenotypes of children urgently hospitalised, and half of all asthma cases were its manifestation. A moderate positive association (r = 0.4; p = 0.002) between airborne pollen concentration and the number of children who sought care was found in hospitalised patients when aeropalynological monitoring and clinic data were compared. Conclusion. The peculiarity of the pollen season in 2023 in the Ryazan region (Central Federal District of the Russian Federation) is the record high concentration of birch pollen for the last 9 years of observations. This led to an increase in the number of children with emergency symptoms of respiratory and cutaneous pollinosis.
- Open Access
- 21 December 2025
- Published by Rostov State Medical University in Medical Herald of the South of Russia
- Vol. 16 (4) , 62-67
Congenital malformation of newborns: Ladd’s syndrome
Ledd's syndrome is a rare form of congenital intestinal obstruction characterized by compression of the duodenum by fetal adhesions and midgut volvulus due to impaired antenatal rotation. The incidence of this condition is 0.8 per 1,000 live births, with boys being twice as likely to be diagnosed. Traditional diagnosis of Ledd's syndrome in newborns is based on clinical assessment and radiographic data. This article presents a clinical case of late detection of Ledd's syndrome in a child aged 1 month and 8 days with a favorable surgical outcome. Ledd's syndrome requires a multidisciplinary approach and a high level of vigilance from neonatologists, pediatricians, and pediatric surgeons to ensure timely diagnosis and prevent life-threatening complications.
- 21 December 2025
- Published by Rostov State Medical University in Medical Herald of the South of Russia
- Vol. 16 (4) , 62-67
Open AccessCongenital malformation of newborns: Ladd’s syndrome
Ledd's syndrome is a rare form of congenital intestinal obstruction characterized by compression of the duodenum by fetal adhesions and midgut volvulus due to impaired antenatal rotation. The incidence of this condition is 0.8 per 1,000 live births, with boys being twice as likely to be diagnosed. Traditional diagnosis of Ledd's syndrome in newborns is based on clinical assessment and radiographic data. This article presents a clinical case of late detection of Ledd's syndrome in a child aged 1 month and 8 days with a favorable surgical outcome. Ledd's syndrome requires a multidisciplinary approach and a high level of vigilance from neonatologists, pediatricians, and pediatric surgeons to ensure timely diagnosis and prevent life-threatening complications.
- 14 December 2025
- Published by Scientific and Practical Reviewed Journal Pulmonology in PULMONOLOGIYA
- Vol. 35 (6)
Ganglioneuroma of the right hemithorax with local intradural spread at the TH10-11 level: a clinical case
Ganglioneuroma is a rare tumor originating from the neural crest, has a benign profile unlike other neuroblastic tumors (neuroblastoma, ganglioneuroblastoma). Ganglioneuromas can be found wherever the vegetative ganglia are located, mainly in the abdominal cavity, pelvis, adrenal glands, mediastinal organs, chest, and spine in children. Ganglioneuroma is usually diagnosed at the age of 7 and is more common in women than in men, with a ratio of about 3 : 2. The disease is asymptomatic or manifests itself with local compression effects; rarely there are nonspecific complaints of abdominal pain or hypertension associated with hypersecretion of adrenaline, norepinephrine, dopamine. The aim of the study was to describe a clinical case of ganglioneuroma of the right hemithorax with local intradural spread at the level of TH10-11 in a 6-year-old child. The aspects of manifestation, diagnosis, differential diagnosis, complications, and treatment of ganglioneuromas are discussed. Conclusion. Chest ganglioneuroma has a favorable prognosis after complete resection, even with infiltration of the spinal canal. Resection may be difficult in the case of massive dimensions and involvement of the vascular membrane. Therefore, the benefits and risks of complete resection should be carefully evaluated. Thus, a feature of the presented clinical case of ganglioneuroma of the right hemithorax with local intradural spread at the level of TH10-11 in a 6-year-old child was its long-term asymptomatic course. Despite the fact that the diagnosis was confirmed histologically, preoperative imaging helped localize and characterize the mass and select the appropriate treatment options.
- 14 December 2025
- Published by Scientific and Practical Reviewed Journal Pulmonology in PULMONOLOGIYA
- Vol. 35 (6)
Ganglioneuroma of the right hemithorax with local intradural spread at the TH10-11 level: a clinical case
Ganglioneuroma is a rare tumor originating from the neural crest, has a benign profile unlike other neuroblastic tumors (neuroblastoma, ganglioneuroblastoma). Ganglioneuromas can be found wherever the vegetative ganglia are located, mainly in the abdominal cavity, pelvis, adrenal glands, mediastinal organs, chest, and spine in children. Ganglioneuroma is usually diagnosed at the age of 7 and is more common in women than in men, with a ratio of about 3 : 2. The disease is asymptomatic or manifests itself with local compression effects; rarely there are nonspecific complaints of abdominal pain or hypertension associated with hypersecretion of adrenaline, norepinephrine, dopamine. The aim of the study was to describe a clinical case of ganglioneuroma of the right hemithorax with local intradural spread at the level of TH10-11 in a 6-year-old child. The aspects of manifestation, diagnosis, differential diagnosis, complications, and treatment of ganglioneuromas are discussed. Conclusion. Chest ganglioneuroma has a favorable prognosis after complete resection, even with infiltration of the spinal canal. Resection may be difficult in the case of massive dimensions and involvement of the vascular membrane. Therefore, the benefits and risks of complete resection should be carefully evaluated. Thus, a feature of the presented clinical case of ganglioneuroma of the right hemithorax with local intradural spread at the level of TH10-11 in a 6-year-old child was its long-term asymptomatic course. Despite the fact that the diagnosis was confirmed histologically, preoperative imaging helped localize and characterize the mass and select the appropriate treatment options.